In Wednesday’s Wall Street session, Relay Therapeutics Inc (NASDAQ:RLAY) shares traded at $2.95, down -6.35% from the previous session.
RLAY stock price is now -1.67% away from the 50-day moving average and -42.60% away from the 200-day moving average. The market capitalization of the company currently stands at $505.76M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $4, Wells Fargo recently initiated with Equal Weight rating for Relay Therapeutics Inc (NASDAQ: RLAY). On September 10, 2024, Jefferies Upgraded its previous ‘Hold’ rating to ‘Buy’ on the stock increasing its target price from $10.60 to quote $16, while ‘Goldman’ rates the stock as ‘Buy’
In other news, Rahmer Peter, insider sold 10,739 shares of the company’s stock on Apr 30 ’25. The stock was sold for $32,217 at an average price of $3.00. Upon completion of the transaction, the insider now directly owns 390,081 shares in the company, valued at $1.15 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 28 ’25, Rahmer Peter sold 1,364 shares of the business’s stock. A total of $4,324 was realized by selling the stock at an average price of $3.17. This leaves the insider owning 400,820 shares of the company worth $1.18 million. A total of 24.59% of the company’s stock is owned by insiders.
During the past 12 months, Relay Therapeutics Inc has had a low of $1.77 and a high of $10.72. As of last week, the company has a debt-to-equity ratio of 0.07, a current ratio of 19.96, and a quick ratio of 19.96.
The net profit margin was -4341.53% and return on equity was -45.46% for RLAY. The company reported revenue of $7.68 million for the quarter, compared to $10.01 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -23.26 percent.
